248 related articles for article (PubMed ID: 35571564)
61. A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma.
Gao X; Tang M; Tian S; Li J; Liu W
Future Oncol; 2021 Apr; 17(12):1533-1544. PubMed ID: 33432837
[TBL] [Abstract][Full Text] [Related]
62. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
63. Construction and validation of a novel immune and tumor mutation burden-based prognostic model in lung adenocarcinoma.
Zhou B; Gao S
Cancer Immunol Immunother; 2022 May; 71(5):1183-1197. PubMed ID: 34635925
[TBL] [Abstract][Full Text] [Related]
64. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
[TBL] [Abstract][Full Text] [Related]
65. Comprehensive analysis of the biological functions of endoplasmic reticulum stress in prostate cancer.
Cen S; Jiang D; Lv D; Xu R; Hou J; Yang Z; Wu P; Xiong X; Gao X
Front Endocrinol (Lausanne); 2023; 14():1090277. PubMed ID: 36967783
[TBL] [Abstract][Full Text] [Related]
66. Comprehensive analysis of the association between tumor-infiltrating immune cells and the prognosis of lung adenocarcinoma.
Pan Y; Sha Y; Wang H; Zhuang H; Ren X; Zhu X; Wei X
J Cancer Res Ther; 2020; 16(2):320-326. PubMed ID: 32474519
[TBL] [Abstract][Full Text] [Related]
67. Identification of endoplasmic reticulum stress-related signature characterizes the tumor microenvironment and predicts prognosis in lung adenocarcinoma.
Wan L; Chen Z; Yang J; Wu G; Xu Y; Cui J; Zhao X
Sci Rep; 2023 Nov; 13(1):19462. PubMed ID: 37945620
[TBL] [Abstract][Full Text] [Related]
68. Identification of Prognostic and Immune Characteristics of Two Lung Adenocarcinoma Subtypes Based on TRPV Channel Family Genes.
Jiang J; Zheng P; Li L
J Membr Biol; 2024 Apr; 257(1-2):115-129. PubMed ID: 38150051
[TBL] [Abstract][Full Text] [Related]
69. Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma.
Xiao L; Li Q; Huang Y; Fan Z; Ma L; Liu B; Yuan X
J Healthc Eng; 2022; 2022():7651758. PubMed ID: 35251577
[TBL] [Abstract][Full Text] [Related]
70. Systematic construction and validation of an immune prognostic model for lung adenocarcinoma.
Luo C; Lei M; Zhang Y; Zhang Q; Li L; Lian J; Liu S; Wang L; Pi G; Zhang Y
J Cell Mol Med; 2020 Jan; 24(2):1233-1244. PubMed ID: 31779055
[TBL] [Abstract][Full Text] [Related]
71. The low expression of NUP62CL indicates good prognosis and high level of immune infiltration in lung adenocarcinoma.
Ren S; Wang W; Zhang C; Sun Y; Sun M; Wang Y; Zhang X; Lu B; Yao L
Cancer Med; 2021 May; 10(10):3403-3412. PubMed ID: 33934535
[TBL] [Abstract][Full Text] [Related]
72. Integrative analyses identified ion channel genes GJB2 and SCNN1B as prognostic biomarkers and therapeutic targets for lung adenocarcinoma.
Lu A; Shi Y; Liu Y; Lin J; Zhang H; Guo Y; Li L; Lin Z; Wu J; Ji D; Wang C
Lung Cancer; 2021 Aug; 158():29-39. PubMed ID: 34111567
[TBL] [Abstract][Full Text] [Related]
73. Development and validation of an immune-related prognostic signature in lung adenocarcinoma.
Sun S; Guo W; Wang Z; Wang X; Zhang G; Zhang H; Li R; Gao Y; Qiu B; Tan F; Gao Y; Xue Q; Gao S; He J
Cancer Med; 2020 Aug; 9(16):5960-5975. PubMed ID: 32592319
[TBL] [Abstract][Full Text] [Related]
74. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
[TBL] [Abstract][Full Text] [Related]
75. Deciphering N
Zhu J; Wang M; Hu D
Biomed Res Int; 2020; 2020():2514230. PubMed ID: 32258108
[TBL] [Abstract][Full Text] [Related]
76. A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining.
Liu J; Hou S; Wang J; Chai Z; Hong X; Zhao T; Sun Z; Bai L; Gao H; Gao J; Chen G
Oxid Med Cell Longev; 2020; 2020():8847226. PubMed ID: 33414898
[TBL] [Abstract][Full Text] [Related]
77. Identification of four metabolic subtypes and key prognostic markers in lung adenocarcinoma based on glycolytic and glutaminolytic pathways.
Zhang J; Wang X; Song C; Li Q
BMC Cancer; 2023 Feb; 23(1):152. PubMed ID: 36782138
[TBL] [Abstract][Full Text] [Related]
78. Prognostic Signature, Immune Features, and Therapeutic Responses of a Novel Ubiquitination-Related Gene Signature in Lung Adenocarcinoma.
Xu M; Gong J
J Oncol; 2022; 2022():2524649. PubMed ID: 36016582
[TBL] [Abstract][Full Text] [Related]
79. Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma.
Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
Aging (Albany NY); 2021 Jul; 13(14):18701-18717. PubMed ID: 34285141
[TBL] [Abstract][Full Text] [Related]
80. A gene-based survival score for lung adenocarcinoma by multiple transcriptional datasets analysis.
Xiong Y; Lei J; Zhao J; Lu Q; Feng Y; Qiao T; Xin S; Han Y; Jiang T
BMC Cancer; 2020 Oct; 20(1):1046. PubMed ID: 33129284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
